TOTEC Pharma

TOTEC Pharma is a privately held pharmaceutical startup dedicated to improving the quality of life for cancer patients by addressing the side effects of radiation therapy. The company's lead focus is on radiation dermatitis, a painful skin condition affecting millions of patients worldwide for which there are currently limited effective treatments. TOTEC utilizes a patented micellar water-oil technology and nano-structured lipid carriers (NLCs) to deliver pharmaceutical-grade Cannabidiol (CBD) topically, targeting CB2 receptors to reduce inflammation and pain. As an affiliate of Aries Science & Technology, TOTEC has partnered with Enveric Biosciences to advance the commercialization of its RCANN™ cannabinoid cream technology. The company's innovative delivery systems are designed to enhance skin penetration and stability, providing a science-backed solution for serious dermatological conditions.